Investor Relations

Consun Pharma Interim results review and NDR Takeaway

date：2019-01-14  Views：10855 times

香港全年最全免费资料大全

香港全年最全免费资料大全

香港全年最全免费资料大全

Prev：Consun Pharma (1681 HK) Unjustifiably low valuation despite solid fundamentals

Next：Consun Pharma (1681 HK) 1H18 results in line

400-930-1681

总机：（86）20-82016888

[email protected]

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • 香港全年最全免费资料大全

    Consun

  • 香港全年最全免费资料大全

    Health Station

  • 香港全年最全免费资料大全

    Micro mall

香港全年最全免费资料大全 工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb